Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed5

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT05172128Not ApplicableCompleted
Effect of Blueberry Supplementation on Alzheimer's Biomarkers
Alzheimer DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2022-02-21
NCT03205709Not ApplicableCompleted
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment
Cognitive DeclineCognitive DisorderCognitive Impairment+3 more
PrincipalinvestigatorStart date: 2017-11-29
NCT01658228Phase 4Completed
Combination Treatment Study for Memory Impairment and Depression
DepressionMild Cognitive Impairment
Studydirector
NCT02241226Not ApplicableCompleted
Self-Directed Biological Transformation Initiative
Healthy
Principalinvestigator

Research Network

Collaboration Network

27 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bradley S Folley, PhD

Norton Healthcare, Louisville KY

Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive DysfunctionDementia+2 more

Worked with same sponsors:

Neuronetrix, Inc.
Collaborated on 1 trial
Similarity Score54%

Davangere P Devanand, MD

Columbia University

Similar
1 trials

Shared therapeutic areas:

Cognitive DeclineCognitive DysfunctionMemory Disorders+2 more

Worked with same sponsors:

Duke UniversityNew York State Psychiatric Institute+1 more
Collaborated on 1 trial
Similarity Score54%

Paul R Solomon, PhD

The Memory Clinic, Bennington VT

Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive DysfunctionDementia+2 more

Worked with same sponsors:

Neuronetrix, Inc.
Collaborated on 1 trial
Similarity Score54%

Carl Sadowsky, MD

Premiere Research Institute, West Palm Beach FL

Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive DysfunctionDementia+2 more

Worked with same sponsors:

Neuronetrix, Inc.
Collaborated on 1 trial
Similarity Score54%

Joel Sneed, PhD

Queens College

Similar
1 trials

Shared therapeutic areas:

Cognitive DeclineCognitive DysfunctionMemory Disorders+2 more

Worked with same sponsors:

Duke UniversityNew York State Psychiatric Institute+1 more
Collaborated on 1 trial
Similarity Score54%

Charles D Smith, MD

Univeristy of Kentucky

Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive DysfunctionDementia+2 more

Worked with same sponsors:

Neuronetrix, Inc.
Collaborated on 1 trial
Similarity Score54%

Andrew E Budson, MD

Boston Center for Memory

Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive DysfunctionDementia+2 more

Worked with same sponsors:

Neuronetrix, Inc.
Collaborated on 1 trial
Similarity Score54%

Davangere Devanand, MD

Columbia University

Moderately Similar
3 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentAlzheimer DiseaseDepression

Worked with same sponsors:

National Institute on Aging (NIA)New York State Psychiatric Institute
Collaborated on 1 trial
Similarity Score34%

Steven Roose, MD

Columbia University

Related
1 trials

Shared therapeutic areas:

DepressionMild Cognitive Impairment

Worked with same sponsors:

National Institute on Aging (NIA)New York State Psychiatric Institute
Collaborated on 1 trial
Similarity Score24%

Gregory Pelton, MD

Columbia University

Related
1 trials

Shared therapeutic areas:

DepressionMild Cognitive Impairment

Worked with same sponsors:

National Institute on Aging (NIA)New York State Psychiatric Institute
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05172128Not ApplicablePrincipalInvestigator

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

Alzheimer DiseaseMild Cognitive Impairment
Completed
NCT03205709Not ApplicablePrincipalInvestigator

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment

Cognitive DeclineCognitive DisorderCognitive Impairment+3 more
Completed
NCT00938665PrincipalInvestigator

Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

Alzheimer DiseaseCognitive ImpairmentDementia+2 more
Completed
NCT01658228Phase 4StudyDirector

Combination Treatment Study for Memory Impairment and Depression

DepressionMild Cognitive Impairment
Completed
NCT02241226Not ApplicablePrincipalInvestigator

Self-Directed Biological Transformation Initiative

Healthy
Completed

All 5 trials loaded